It has recently been shown that CD73's expression is abnormally up-regulated in a wide spectrum of cancers, including gastric cancer (GC), colorectal cancer (CRC), breast cancer (BC), and hepatocellular carcinoma (HCC) [4, 5]. This evidence concerns the gene NT5E and colorectal cancer.